NCT01004510View on ClinicalTrials.gov

Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer

PHASE2TerminatedINTERVENTIONAL

Enrollment

3

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

April 30, 2011

Conditions

Malignant Pleural EffusionNon Small Cell Lung Cancer

Interventions

DRUG

zoledronic acid

Zoledronic acid (Zometa) 4mg IV every 4 weeks for 3 treatments with chemotherapy as selected by treating physician

Trial Locations (1)

14621

Rochester General Hospital, Rochester

Sponsors

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Peter Bushunow MD

OTHER